TIS tissue therapies limited

This is a quote from an email from Nigel Johnson (Chief...

  1. 2,243 Posts.
    lightbulb Created with Sketch. 109

    This is a quote from an email from Nigel Johnson (Chief Operating Officer)to THaitang YESTERDAY:

    "To respond to the second part of you question, the situation (ie the delay) is not contingent upon the EU/AUS trial.

    The Board and management continuously review the companies financial position and is happy with the cash position."

    Bloody liars
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.